Literature DB >> 23827970

Pseudolaric acid B induces apoptosis in U937 human leukemia cells via caspase-9‑mediated activation of the mitochondrial death pathway.

Jia-He Wang1, Liang Kan, Lin-Hua Shu, Nan Wang, Nai-Jing Li, Meng Zhang.   

Abstract

Numerous studies have demonstrated that pseudolaric acid B (PAB) promotes apoptosis in several cancer cell lines. However, thus far, the effect of PAB on human leukemia cells has not been evaluated. In the present study, the antitumor activity and molecular mechanisms of PAB in human leukemia U937 cells were investigated. It was demonstrated that PAB induced U937 cell apoptosis, which was confirmed by typical morphological changes and Annexin V‑fluorescein isothiocyanate staining. PAB was observed to activate a caspase‑dependent apoptotic pathway in U937 cells through the regulation of the Bcl‑2 family protein-mediated mitochondrial pathway. Furthermore, the activities of caspase‑3 and -9 were increased following treatment with PAB. In conclusion, to the best of our knowledge, this study demonstrated for the first time that PAB was able to enhance the apoptosis of U937 cells, at least in part, through the activation of the mitochondrial death pathway. Moreover, the activation of caspase‑3 and -9 mediated the apoptotic induction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23827970     DOI: 10.3892/mmr.2013.1571

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  2 in total

1.  Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells.

Authors:  Wei-Wei Wang; Lin Lu; Tian-Hao Bao; Hong-Miao Zhang; Jing Yuan; Wei Miao; Shu-Fen Wang; Zhi-Cheng Xiao
Journal:  J Mol Neurosci       Date:  2015-10-29       Impact factor: 3.444

Review 2.  A Systematic Review of the Immune-Regulating and Anticancer Activities of Pseudolaric Acid B.

Authors:  Mei-Lun Liu; Dan Sun; Tan Li; Hong Chen
Journal:  Front Pharmacol       Date:  2017-06-28       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.